BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bacillus,lactobacillus,streptococcus,saccharomyces probiotic - Helicobacter |
👪
Probiotics in 14-day triple therapy for Asian pediatric patients with Helicobacter pylori infection: a network meta-analysis. Oncotarget (Oncotarget ) Vol: 8 Issue 56 Pages: 96409-96418 Pub: 2017 Nov 10 Epub: 2017 Oct 7 Authors Wen J , Peng P , Chen P , Zeng L , Pan Q , Wei W , He J , Html Article Publication |
| bacillus,lactobacillus,streptococcus,saccharomyces probiotic - Helicobacter |
📓
Gut microbiota and metabolic modulation by supplementation of polysaccharide-producing Bacillus licheniformis from Tibetan Yaks: A comprehensive multi-omics analysis. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 254 Issue Pt 2 Pages: 127808 Pub: 2024 Jan Epub: 2023 Nov 4 Authors Zeng Z , Quan C , Zhou S , Gong S , Iqbal M , Kulyar MF , Nawaz S , Li K , Li J , Publication |
| bacillus,lactobacillus,streptococcus,saccharomyces probiotic - Helicobacter |
📓
Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates. The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 61 Issue 1 Pages: 139-42 Pub: 2008 Jan Epub: 2007 Oct 26 Authors López-Brea M , Alarcón T , Domingo D , Díaz-Regañón J , Publication Publication |
| bacillus,lactobacillus,streptococcus,saccharomyces probiotic - Helicobacter |
👪
Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial. Frontiers in medicine (Front Med (Lausanne) ) Vol: 8 Issue Pages: 776955 Pub: 2021 Epub: 2021 Nov 18 Authors Zhao Y , Yang Y , Aruna , Xiao J , Song J , Huang T , Li S , Kou J , Huang L , Ji D , Xiong S , Peng W , Xu S , Cheng B , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
